Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial - Concepedia

Concepedia

Publication | Open Access

Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial

DOI Full Paper Access

156

Citations

40

References

2003

Year

Jean-François Dhainaut, Pierre‐François Laterre, Jonathan Janes, Gordon R. Bernard, Antonio Artigas, Jan Bakker, Hanno Riess, Bruce R. Basson, Julien Charpentier, Barbara G. Utterback,

Intensive Care Medicine

Critical Care MedicineSevere Sepsis PatientsProwess TrialClinical TherapeuticSepsisPharmacotherapySepsis PhenotypingMedicineDrotrecogin AlfaCritical Emergency Medicine

References

	Year	Citations

Page 1

Page 1